免疫细胞工程市场：按细胞类型、产品类型、适应症、应用、最终用户和地区划分

免疫细胞工程市场在2025年估计为42.3亿美元，预计到2032年将达到175.1亿美元，2025年至2032年的年复合成长率（CAGR）为22.5％。

免疫细胞工程是近年来备受关注的一个领域，因其有望彻底改变包括癌症在内的多种疾病的治疗。免疫细胞工程涉及对免疫细胞进行操控或改造，以增强其靶向和摧毁癌细胞及其他病原体的能力。这个新兴领域结合了免疫学、分子生物学和基因工程的原理，旨在开发创新治疗方法。

免疫系统在识别和清除体内外来入侵者和异常细胞方面发挥着至关重要的作用。然而，对于某些疾病，免疫反应可能不足或无效。透过基因工程改造免疫细胞，科学家可以提高其识别和攻击特定目标（例如癌细胞）的能力。

市场动态：

免疫细胞工程市场受多个关键因素驱动。首先，癌症、自体免疫疾病和感染疾病等各种疾病的发生率正在上升。这些疾病的常规治疗方法通常有其局限性，因此需要创新的治疗方法。

其次，基因编辑技术的进步显着提高了免疫细胞工程的效率和精准度。 CRISPR/Cas9等基因编辑工具使得修改免疫细胞和增强其治疗潜力变得更加容易。这些技术进步预计将推动免疫细胞工程市场的成长。

然而，仍存在一些挑战和阻碍因素需要克服。其中一项主要挑战是免疫细胞工程疗法的高成本。这些治疗方法的开发和生产过程复杂，需要专门的设施和专业知识。这限制了这些治疗方法的可近性，尤其是在新兴国家。

例如，2022年12月，製药公司吉利德科学宣布收购临床阶段生物技术公司Tmunity Therapeutics Inc. 透过此次收购，吉利德科学获得了临床前和临床项目，包括一个「装甲」CAR T技术平台，该平台可潜在地应用于多种CAR T细胞以增强抗肿瘤活性，并有助于增强CAR T细胞产品的製造过程。

本研究的主要特点

• 本报告对全球免疫细胞工程市场进行了详细分析，并以 2024 年为基准年，提供了 2025 年至 2032 年预测期内的市场规模和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球免疫细胞工程市场的主要企业。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球免疫细胞工程市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 可以透过用于分析全球免疫细胞工程市场的各种策略矩阵来促进相关人员的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

第四章免疫细胞工程市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 免疫细胞工程市场（依细胞类型），2020 年至 2032 年

• T细胞
• NK细胞
• 树突状细胞
• 癌细胞
• 干细胞
• 其他的

6. 免疫细胞工程市场（依产品类型），2020 年至 2032 年

• 耗材
• 装置
• 软体

7. 免疫细胞工程市场（依适应症划分），2020 年至 2032 年

• 心血管疾病
• 呼吸系统疾病
• 感染疾病
• 癌症
• 神经系统疾病
• 其他的

第 8 章 免疫细胞工程市场（依应用），2020 年至 2032 年

• 研究用途
• 细胞治疗与再生医学
• 其他的

9. 免疫细胞工程市场（依最终用户划分），2020 年至 2032 年

• 製药和生物技术公司
• 医院和诊所
• 学术研究所
• 细胞库
• 其他的

第 10 章免疫细胞工程市场（按地区划分），2020 年至 2032 年

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章竞争格局

• Thermo Fisher Scientific,Inc.
• Merck KGaA
• Danaher Corporation
• Lonza
• Miltenyi Biotec
• Takara Bio Inc.
• Sartoroius CellGenix GmbH
• FUJIFILM Irvine Scientific
• Agilent Technologies,Inc.
• Bio-Techne
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Charles River Laboratories
• Creative Bioarray
• Sartorius AG
• Novogene Co, Ltd.
• AGC Biologics
• Catalent, Inc
• WuXi AppTec
• Discovery Life Sciences

第十二章 章节

• 调查方法
• 关于出版商

Immune Cell Engineering Market is estimated to be valued at USD 4.23 Bn in 2025 and is expected to reach USD 17.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.5% from 2025 to 2032.

Immune cell engineering is a field that has gained significant attention in recent years due to its potential to revolutionize the treatment of various diseases, including cancer. It involves the manipulation and modification of immune cells to enhance their ability to target and destroy cancer cells or other pathogens. This emerging field combines principles of immunology, molecular biology, and genetic engineering to develop innovative therapies.

The immune system plays a critical role in recognizing and eliminating foreign invaders or abnormal cells in the body. However, in some cases, the immune response may be insufficient or ineffective against certain diseases. By genetically modifying immune cells, scientists can enhance their ability to recognize and attack specific targets, such as cancer cells.

Market Dynamics:

The immune cell engineering market is driven by several key factors. Firstly, there is a growing prevalence of various diseases, including cancer, autoimmune disorders, and infectious diseases. As traditional treatment options for these diseases often have limitations, there is a need for innovative therapeutic approaches.

Secondly, advancements in gene-editing technologies have significantly improved the efficiency and precision of immune cell engineering. Gene-editing tools such as CRISPR/Cas9 have made it easier to modify immune cells and enhance their therapeutic potential. These technological innovations are expected to drive the growth of the immune cell engineering market.

However, there are also several challenges and restraints that need to be addressed. One of the main challenges is the high cost associated with immune cell engineering therapies. The development and manufacturing processes for these therapies are complex and require specialized facilities and expertise. This has limited the accessibility of these therapies, particularly in developing countries.

For instance, in December 2022, Gilead Sciences, Inc., a pharmaceutical company, announced the acquisition of Tmunity Therapeutics Inc., a clinical-stage biotechnology company. The acquisition provided Gilead Sciences, Inc. with preclinical and clinical programs, including an "armored" CAR T technology platform that has the potential to be applied to a variety of CAR T cells to enhance anti-tumor activity, and helps to enhance manufacturing processes for of CAR T cells product.

Key features of the study:

• This report provides in-depth analysis of the global immune cell engineering market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global immune cell engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza, Miltenyi Biotec, Takara Bio Inc., Sartoroius CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technologies, Inc., Bio-Techne, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Charles River Laboratories, Creative Bioarray, Sartorius AG, Novogene Co, Ltd., AGC Biologics, Catalent, Inc., WuXi AppTec, Discovery Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global immune cell engineering market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immune cell engineering market

Detailed Segmentation:

• Global Immune Cell Engineering Market, By Cell Type
  • T Cells
  • NK Cells
  • Dendritic Cells
  • Tumor Cells
  • Stem Cells
  • Others
• Global Immune Cell Engineering Market, By Product
  • Consumables
  • Instruments
  • Software
• Global Immune Cell Engineering Market, By Disease Indication
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Cancer
  • Neurological Diseases
  • Others
• Global Immune Cell Engineering Market, By Application
  • Research Applications
  • Cell Therapy & Regenerative Medicine
  • Others
• Global Immune Cell Engineering Market, By End User
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Cell Banks
  • Others
• Global Immune Cell Engineering Market, By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza
  • Miltenyi Biotec
  • Takara Bio Inc.
  • Sartoroius CellGenix GmbH
  • FUJIFILM Irvine Scientific
  • Agilent Technologies, Inc.
  • Bio-Techne
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Charles River Laboratories
  • Creative Bioarray
  • Sartorius AG
  • Novogene Co, Ltd.
  • AGC Biologics
  • Catalent, Inc
  • WuXi AppTec
  • Discovery Life Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Immune Cell Engineering Market, By Cell Type
  • Market Immune Cell Engineering Market, By Product
  • Market Immune Cell Engineering Market, By Disease Indication
  • Market Immune Cell Engineering Market, By Application
  • Market Immune Cell Engineering Market, By End User
  • Market Immune Cell Engineering Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Immune Cell Engineering Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Immune Cell Engineering Market, By Cell Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• T Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• NK Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Dendritic Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tumor Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Immune Cell Engineering Market, By Product, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Immune Cell Engineering Market, By Disease Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Respiratory Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neurological Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Immune Cell Engineering Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Research Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cell Therapy & Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Immune Cell Engineering Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cell Banks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Immune Cell Engineering Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Thermo Fisher Scientific,Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lonza
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Miltenyi Biotec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Takara Bio Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sartoroius CellGenix GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• FUJIFILM Irvine Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies,Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Techne
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Bioarray
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sartorius AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novogene Co, Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AGC Biologics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Catalent, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• WuXi AppTec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Discovery Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us